JP2010522693A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010522693A5 JP2010522693A5 JP2009544303A JP2009544303A JP2010522693A5 JP 2010522693 A5 JP2010522693 A5 JP 2010522693A5 JP 2009544303 A JP2009544303 A JP 2009544303A JP 2009544303 A JP2009544303 A JP 2009544303A JP 2010522693 A5 JP2010522693 A5 JP 2010522693A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- group
- unsubstituted
- hydrogen
- phe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 15
- 150000002431 hydrogen Chemical class 0.000 claims 13
- 125000004404 heteroalkyl group Chemical group 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 3
- AGGWFDNPHKLBBV-YUMQZZPRSA-N (2s)-2-[[(2s)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoic acid Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=O AGGWFDNPHKLBBV-YUMQZZPRSA-N 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims 2
- JKHXYJKMNSSFFL-IUCAKERBSA-N Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN JKHXYJKMNSSFFL-IUCAKERBSA-N 0.000 claims 2
- 229910052799 carbon Chemical group 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- 108010073969 valyllysine Proteins 0.000 claims 2
- KQRHTCDQWJLLME-XUXIUFHCSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-aminopropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N KQRHTCDQWJLLME-XUXIUFHCSA-N 0.000 claims 1
- WEZDRVHTDXTVLT-GJZGRUSLSA-N 2-[[(2s)-2-[[(2s)-2-[(2-aminoacetyl)amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 WEZDRVHTDXTVLT-GJZGRUSLSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- QXRNAOYBCYVZCD-BQBZGAKWSA-N Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN QXRNAOYBCYVZCD-BQBZGAKWSA-N 0.000 claims 1
- -1 D-Phe-Phe-Lys Chemical compound 0.000 claims 1
- 108010009504 Gly-Phe-Leu-Gly Proteins 0.000 claims 1
- YLEIWGJJBFBFHC-KBPBESRZSA-N Gly-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 YLEIWGJJBFBFHC-KBPBESRZSA-N 0.000 claims 1
- VAXBXNPRXPHGHG-BJDJZHNGSA-N Ile-Ala-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)N VAXBXNPRXPHGHG-BJDJZHNGSA-N 0.000 claims 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 claims 1
- LSPYFSHXDAYVDI-SRVKXCTJSA-N Leu-Ala-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C LSPYFSHXDAYVDI-SRVKXCTJSA-N 0.000 claims 1
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 claims 1
- MIDZLCFIAINOQN-WPRPVWTQSA-N Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 MIDZLCFIAINOQN-WPRPVWTQSA-N 0.000 claims 1
- FADYJNXDPBKVCA-STQMWFEESA-N Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 FADYJNXDPBKVCA-STQMWFEESA-N 0.000 claims 1
- RBRNEFJTEHPDSL-ACRUOGEOSA-N Phe-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RBRNEFJTEHPDSL-ACRUOGEOSA-N 0.000 claims 1
- QRZVUAAKNRHEOP-GUBZILKMSA-N Val-Ala-Val Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O QRZVUAAKNRHEOP-GUBZILKMSA-N 0.000 claims 1
- 108010054982 alanyl-leucyl-alanyl-leucine Proteins 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical group OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 108010054155 lysyllysine Proteins 0.000 claims 1
- 150000004712 monophosphates Chemical group 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000001151 peptidyl group Chemical group 0.000 claims 1
- 108010024607 phenylalanylalanine Proteins 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000006850 spacer group Chemical group 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 claims 1
- 125000002264 triphosphate group Chemical group [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 claims 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N CC1CCCC1 Chemical compound CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88246106P | 2006-12-28 | 2006-12-28 | |
| US99130007P | 2007-11-30 | 2007-11-30 | |
| PCT/US2007/089100 WO2008083312A2 (en) | 2006-12-28 | 2007-12-28 | Chemical linkers and cleavable substrates and conjugates thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010522693A JP2010522693A (ja) | 2010-07-08 |
| JP2010522693A5 true JP2010522693A5 (cg-RX-API-DMAC7.html) | 2011-02-24 |
Family
ID=39589219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009544303A Pending JP2010522693A (ja) | 2006-12-28 | 2007-12-28 | 化学リンカー及び切断可能な基質及びそれらの抱合体 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8461117B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2114454A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010522693A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090098901A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101795711A (cg-RX-API-DMAC7.html) |
| AR (1) | AR067837A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007342052A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0719626A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2674055C (cg-RX-API-DMAC7.html) |
| CL (1) | CL2007003849A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA019962B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL199416A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009007147A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20092733L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ578324A (cg-RX-API-DMAC7.html) |
| SG (1) | SG170070A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI412367B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008083312A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (142)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2630483C (en) * | 2005-12-08 | 2015-05-19 | Medarex, Inc. | Human monoclonal antibodies to o8e |
| CA2678514A1 (en) | 2007-02-21 | 2008-08-28 | Medarex, Inc. | Chemical linkers with single amino acids and conjugates thereof |
| WO2009026274A1 (en) | 2007-08-22 | 2009-02-26 | Medarex, Inc. | Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions |
| US8268970B2 (en) | 2007-10-01 | 2012-09-18 | Bristol-Myers Squibb Company | Human antibodies that bind mesothelin, and uses thereof |
| MX2010005830A (es) * | 2007-11-30 | 2010-09-14 | Bristol Myers Squibb Co | Conjugado de anticuerpo monoclonal anti-b7h4 - farmaco y metodos de uso del mismo. |
| AR072999A1 (es) | 2008-08-11 | 2010-10-06 | Medarex Inc | Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos |
| RU2562232C2 (ru) | 2008-11-03 | 2015-09-10 | Синтарга Б.В. | Новые аналоги сс-1065 и их конъюгаты |
| AU2010221186B2 (en) | 2009-03-05 | 2013-08-22 | E. R. Squibb & Sons, L.L.C. | Fully human antibodies specific to CADM1 |
| US8394922B2 (en) | 2009-08-03 | 2013-03-12 | Medarex, Inc. | Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| WO2011034668A1 (en) | 2009-08-07 | 2011-03-24 | Ohmx Corporation | Enzyme triggered redox altering chemical elimination (e-trace) immunoassay |
| US9250234B2 (en) | 2011-01-19 | 2016-02-02 | Ohmx Corporation | Enzyme triggered redox altering chemical elimination (E-TRACE) immunoassay |
| US9624522B2 (en) | 2009-08-07 | 2017-04-18 | Ohmx Corporation | Single, direct detection of hemoglobin A1c percentage using enzyme triggered redox altering chemical elimination (e-trace) immunoassay |
| AU2011239507B2 (en) * | 2010-04-15 | 2015-04-09 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| PT3056203T (pt) | 2010-04-21 | 2018-02-15 | Syntarga Bv | Conjugados de análogos de cc-1065 e ligantes bifuncionais |
| US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
| US8501930B2 (en) * | 2010-12-17 | 2013-08-06 | Arrowhead Madison Inc. | Peptide-based in vivo siRNA delivery system |
| US8852599B2 (en) * | 2011-05-26 | 2014-10-07 | Bristol-Myers Squibb Company | Immunoconjugates, compositions for making them, and methods of making and use |
| JP2014532720A (ja) | 2011-11-04 | 2014-12-08 | オームクス コーポレイション | バイオセンサーにおいて使用される新規化学 |
| EP2802669A1 (en) | 2012-01-09 | 2014-11-19 | Ohmx Corporation | Enzyme cascade methods for e-trace assay signal amplification |
| LT2814829T (lt) | 2012-02-13 | 2017-02-27 | Bristol-Myers Squibb Company | En-diino junginiai, jų konjugatai ir jų panaudojimas bei jo būdai |
| EP2858659B1 (en) | 2012-06-08 | 2019-12-25 | Bioverativ Therapeutics Inc. | Procoagulant compounds |
| WO2013185114A2 (en) | 2012-06-08 | 2013-12-12 | Biogen Idec Ma Inc. | Chimeric clotting factors |
| UY34887A (es) | 2012-07-02 | 2013-12-31 | Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware | Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos |
| EP3121288A1 (en) | 2012-07-27 | 2017-01-25 | Ohmx Corporation | Electronic measurements of monolayers following homogeneous reactions of their components |
| JP2015529809A (ja) | 2012-07-27 | 2015-10-08 | オームクス コーポレイション | 酵素及び他の標的分析物の存在及び活性の切断前検出後の単分子層の電気測定 |
| RU2015129800A (ru) | 2012-12-21 | 2017-01-30 | Биоэллаенс К. В. | Гидрофильные саморазрушающиеся линкеры и их конъюгаты |
| PT2956173T (pt) | 2013-02-14 | 2017-06-26 | Bristol Myers Squibb Co | Compostos de tubulisina, métodos de produção e utilização |
| CN110143999B (zh) | 2013-03-15 | 2023-12-05 | 酵活英属哥伦比亚省公司 | 具细胞毒性和抗有丝分裂的化合物以及其使用方法 |
| WO2014177771A1 (en) | 2013-05-02 | 2014-11-06 | Glykos Finland Oy | Conjugates of a glycoprotein or a glycan with a toxic payload |
| MX2016001862A (es) * | 2013-08-12 | 2016-08-03 | Genentech Inc | Compuestos de conjugado anticuerpo-farmaco dimerico de 1-(clorometil)-2,3-dihidro-1h-benzo[e]indol, y metodos de uso y tratamiento. |
| BR112016013258A2 (pt) | 2013-12-16 | 2018-01-16 | Genentech Inc | composto conjugado anticorpo-droga, composição farmacêutica, método para tratar câncer e kit |
| JP6560681B2 (ja) | 2013-12-27 | 2019-08-14 | ザイムワークス インコーポレイティド | 薬物結合体のためのスルホンアミド含有連結系 |
| JP6419844B2 (ja) | 2014-01-10 | 2018-11-07 | シントン・バイオファーマシューティカルズ・ビー．ブイ．Ｓｙｎｔｈｏｎ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｂ．Ｖ． | Ｃｙｓ連結された抗体−薬物コンジュゲートの精製方法 |
| JP6644701B2 (ja) | 2014-03-20 | 2020-02-12 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 安定化したフィブロネクチンベーススキャフォールド分子 |
| MY181896A (en) | 2014-06-06 | 2021-01-12 | Bristol Myers Squibb Co | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof |
| US9950077B2 (en) | 2014-06-20 | 2018-04-24 | Bioalliance C.V. | Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using thereof |
| DK3160513T3 (da) | 2014-06-30 | 2020-04-06 | Glykos Finland Oy | Saccharidderivat af en toksisk payload og antistofkonjugater deraf |
| WO2016025539A1 (en) | 2014-08-11 | 2016-02-18 | Ohmx Corporation | Enzyme triggered redox altering chemical elimination (-trace) assay with multiplexing capabilities |
| CN107108694B (zh) * | 2014-09-11 | 2022-05-03 | 西雅图基因公司 | 含叔胺药物物质的靶向递送 |
| KR102494557B1 (ko) | 2014-09-17 | 2023-02-02 | 자임워크스 비씨 인코포레이티드 | 세포독성 및 항유사분열성 화합물, 그리고 이를 이용하는 방법 |
| CN104356048B (zh) * | 2014-11-02 | 2016-08-24 | 浙江医药高等专科学校 | 环己烷羧酸酰胺类衍生物、其制备方法和用途 |
| US10077287B2 (en) | 2014-11-10 | 2018-09-18 | Bristol-Myers Squibb Company | Tubulysin analogs and methods of making and use |
| US10100129B2 (en) | 2014-11-21 | 2018-10-16 | Bristol-Myers Squibb Company | Antibodies against CD73 and uses thereof |
| EA038349B1 (ru) | 2014-11-21 | 2021-08-12 | Бристол-Маерс Сквибб Компани | Антитела, содержащие модифицированные константные участки тяжелой цепи |
| EP3223866B1 (en) | 2014-11-25 | 2023-03-08 | Bristol-Myers Squibb Company | Methods and compositions for 18f-radiolabeling of the fibronectin type (iii) domain |
| EP3702367B1 (en) | 2014-11-25 | 2024-05-15 | Bristol-Myers Squibb Company | Novel pd-l1 binding polypeptides for imaging |
| PL3233912T3 (pl) | 2014-12-19 | 2021-12-27 | Regenesance B.V. | Przeciwciała, które wiążą ludzkie c6 oraz ich zastosowania |
| WO2016100834A2 (en) | 2014-12-19 | 2016-06-23 | Ohmx Corporation | Competitive enzymatic assays |
| ES2747386T3 (es) | 2015-01-14 | 2020-03-10 | Bristol Myers Squibb Co | Dímeros de benzodiacepina unidos por heteroarileno, conjugados de los mismos y métodos de preparación y uso |
| MA41374A (fr) * | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci |
| WO2016144608A1 (en) | 2015-03-10 | 2016-09-15 | Bristol-Myers Squibb Company | Antibodies conjugatable by transglutaminase and conjugates made therefrom |
| HUE061253T2 (hu) | 2015-05-29 | 2023-06-28 | Bristol Myers Squibb Co | Antitestek OX40 ellen és azok felhasználásai |
| WO2017048728A1 (en) * | 2015-09-14 | 2017-03-23 | Rutgers, The State University Of New Jersey | Targeted conjugates |
| EP3353198B1 (en) | 2015-09-23 | 2020-06-17 | Bristol-Myers Squibb Company | Glypican-3binding fibronectin based scafflold molecules |
| EP3165237B1 (en) | 2015-11-03 | 2018-12-19 | Industrial Technology Research Institute | Antibody-drug conjugate (adc) and method for forming the same |
| JP6983776B2 (ja) | 2015-11-19 | 2021-12-17 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | グルココルチコイド誘発腫瘍壊死因子受容体（ｇｉｔｒ）に対する抗体およびその使用 |
| GB2545169B (en) * | 2015-12-01 | 2019-10-09 | Ellipses Pharma Ltd | Taxane Prodrug Comprising A Membrane Type Matrix Metalloproteinase Cleavage Site |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| CA3006000A1 (en) | 2015-12-04 | 2017-06-08 | Seattle Genetics, Inc. | Conjugates of quaternized tubulysin compounds |
| EP3394096A1 (en) | 2015-12-21 | 2018-10-31 | Bristol-Myers Squibb Company | Variant antibodies for site-specific conjugation |
| MX395252B (es) | 2016-01-08 | 2025-03-25 | Altrubio Inc | Anticuerpos tetravalentes anti ligando-1 de glicoproteina p-selectina (psgl-1) y usos de estos. |
| KR20220033522A (ko) | 2016-03-04 | 2022-03-16 | 브리스톨-마이어스 스큅 컴퍼니 | 항-cd73 항체와의 조합 요법 |
| MY198114A (en) | 2016-04-15 | 2023-08-04 | Macrogenics Inc | Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof |
| WO2017210335A1 (en) | 2016-06-01 | 2017-12-07 | Bristol-Myers Squibb Company | Imaging methods using 18f-radiolabeled biologics |
| CN109562195A (zh) | 2016-06-01 | 2019-04-02 | 百时美施贵宝公司 | 用pd-l1结合多肽进行pet成像 |
| EP4512829A3 (en) | 2016-07-14 | 2025-06-11 | Bristol-Myers Squibb Company | Antibodies against tim3 and uses thereof |
| EP3500574B1 (en) | 2016-08-19 | 2021-11-24 | Bristol-Myers Squibb Company | Seco-cyclopropapyrroloindole compounds, antibody-drug conjugates thereof, and methods of making and use |
| US20190218294A1 (en) | 2016-09-09 | 2019-07-18 | Bristol-Myers Squibb Company | Use of an anti-pd-1 antibody in combination with an anti-mesothelin antibody in cancer treatment |
| WO2018064094A1 (en) | 2016-09-28 | 2018-04-05 | Bristol-Myers Squibb Company | Enantioselective synthesis of pyrroloindole compounds |
| IL310865A (en) * | 2016-10-17 | 2024-04-01 | Pfizer | Antibodies against EDB and antibody-drug conjugates |
| US10398783B2 (en) | 2016-10-20 | 2019-09-03 | Bristol-Myers Squibb Company | Antiproliferative compounds and conjugates made therefrom |
| KR102573778B1 (ko) | 2017-02-17 | 2023-08-31 | 브리스톨-마이어스 스큅 컴퍼니 | 알파-시뉴클레인에 대한 항체 및 그의 용도 |
| EP3621642B1 (en) | 2017-05-10 | 2024-09-18 | Zhejiang Shimai Pharmaceutical Co., Ltd. | Human monoclonal antibodies against lag3 and uses thereof |
| EP3630189A4 (en) | 2017-05-24 | 2021-06-23 | The Board of Regents of The University of Texas System | LINKER FOR ANTIBODY MEDICINAL CONJUGATES |
| US20200299400A1 (en) | 2017-05-25 | 2020-09-24 | Bristol-Myers Squibb Company | Antibodies comprising modified heavy constant regions |
| ES2919779T3 (es) | 2017-06-20 | 2022-07-28 | Imbria Pharmaceuticals Inc | Derivado de 1-[(2,3,4-trimetoxifenil)metil]-piperazina, composiciones del mismo y métodos para aumentar la eficiencia del metabolismo cardíaco |
| US10494370B2 (en) | 2017-08-16 | 2019-12-03 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor |
| US10472361B2 (en) | 2017-08-16 | 2019-11-12 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor |
| US10508115B2 (en) | 2017-08-16 | 2019-12-17 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor |
| US10487084B2 (en) | 2017-08-16 | 2019-11-26 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor |
| US10457681B2 (en) | 2017-08-16 | 2019-10-29 | Bristol_Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor |
| EP3694552A1 (en) | 2017-10-10 | 2020-08-19 | Tilos Therapeutics, Inc. | Anti-lap antibodies and uses thereof |
| CN120192415A (zh) | 2018-01-12 | 2025-06-24 | 百时美施贵宝公司 | 抗tim3抗体及其用途 |
| EP3768715A1 (en) | 2018-03-23 | 2021-01-27 | Bristol-Myers Squibb Company | Antibodies against mica and/or micb and uses thereof |
| EP3774902A1 (en) | 2018-04-02 | 2021-02-17 | Bristol-Myers Squibb Company | Anti-trem-1 antibodies and uses thereof |
| US11485741B2 (en) | 2018-04-24 | 2022-11-01 | Bristol-Myers Squibb Company | Macrocyclic toll-like receptor 7 (TLR7) agonists |
| WO2019246445A1 (en) | 2018-06-20 | 2019-12-26 | The Research Foundation For The State University Of New York | Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same |
| US11884729B2 (en) | 2018-06-29 | 2024-01-30 | ApitBio, Inc | Anti-L1CAM antibodies and uses thereof |
| US11554120B2 (en) | 2018-08-03 | 2023-01-17 | Bristol-Myers Squibb Company | 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor |
| AU2019338221B2 (en) * | 2018-09-12 | 2024-04-04 | Technische Universität München | CXCR4-targeted diagnostic and therapeutic agents with reduced species selectivity |
| EA202190755A1 (ru) * | 2018-09-12 | 2021-06-11 | Технише Универзитет Мюнхен | Агенты для терапии и диагностики рака |
| WO2020076969A2 (en) | 2018-10-10 | 2020-04-16 | Tilos Therapeutics, Inc. | Anti-lap antibody variants and uses thereof |
| US12318382B2 (en) | 2018-10-17 | 2025-06-03 | Imbria Pharmaceuticals, Inc. | Methods of treating rheumatic diseases using trimetazidine-based compounds |
| BR112021008293A2 (pt) | 2018-11-09 | 2021-08-03 | Byondis B.V. | composição, método, e, método para liberar/aprovar um lote de conjugado de anticorpo-fármaco |
| WO2020112781A1 (en) | 2018-11-28 | 2020-06-04 | Bristol-Myers Squibb Company | Antibodies comprising modified heavy constant regions |
| DK3886914T3 (da) | 2018-11-30 | 2023-07-03 | Bristol Myers Squibb Co | Antistof omfattende en glutaminholdig letkæde-c-terminal forlængelse, konjugater deraf og fremgangsmåder samt anvendelser |
| US12139551B2 (en) | 2018-12-03 | 2024-11-12 | Bristol-Myers Squibb Company | Anti-IDO antibody and uses thereof |
| CN115671286B (zh) | 2018-12-04 | 2023-12-08 | 田德扬 | 用于递送抗癌剂的立体复合物 |
| EP3890764A2 (en) | 2018-12-06 | 2021-10-13 | CytomX Therapeutics, Inc. | Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof |
| CN113544155A (zh) | 2018-12-12 | 2021-10-22 | 百时美施贵宝公司 | 经修饰用于转谷氨酰胺酶缀合的抗体、其缀合物以及方法和用途 |
| CN109762067B (zh) | 2019-01-17 | 2020-02-28 | 北京天广实生物技术股份有限公司 | 结合人Claudin 18.2的抗体及其用途 |
| KR20230128134A (ko) | 2019-01-22 | 2023-09-01 | 브리스톨-마이어스 스큅 컴퍼니 | Il-7r 알파 서브유닛에 대한 항체 및 이의 용도 |
| AU2020240135A1 (en) | 2019-03-21 | 2021-10-14 | Lonza Sales Ag | Extracellular vesicles for vaccine delivery |
| KR20210141554A (ko) | 2019-03-21 | 2021-11-23 | 코디악 바이오사이언시즈, 인크. | 세포외 소포 접합체 및 이의 용도 |
| CN114008069A (zh) | 2019-04-17 | 2022-02-01 | 科迪亚克生物科学公司 | 外来体和aav的组合物 |
| EP3963085A4 (en) * | 2019-05-01 | 2022-09-14 | The University of North Carolina at Chapel Hill | RNA-BINDING PROTEIN INHIBITORS, COMPOSITIONS THEREOF, AND THERAPEUTIC USES THEREOF |
| EP3994158A1 (en) | 2019-07-03 | 2022-05-11 | Codiak BioSciences, Inc. | Extracellular vesicles targeting t cells and uses thereof |
| JP2022540674A (ja) | 2019-07-15 | 2022-09-16 | ブリストル－マイヤーズ スクイブ カンパニー | 抗ｔｒｅｍ－１抗体およびその使用 |
| WO2021011681A1 (en) | 2019-07-15 | 2021-01-21 | Bristol-Myers Squibb Company | Antibodies against human trem-1 and uses thereof |
| MX2022001767A (es) | 2019-08-14 | 2022-06-09 | Codiak Biosciences Inc | Construcciones de vesículas-oligonucleótidos antisentido (aso) extracelulares que se dirigen a transductor de señal y activador de la transcripción 6 (stat6). |
| KR20220078565A (ko) | 2019-08-14 | 2022-06-10 | 코디악 바이오사이언시즈, 인크. | 분자에 연결된 세포외 소포 및 이의 용도 |
| CN114729366A (zh) | 2019-08-14 | 2022-07-08 | 科迪亚克生物科学公司 | 靶向CEBP/β的细胞外囊泡-ASO构建体 |
| EP4013872A1 (en) | 2019-08-14 | 2022-06-22 | Codiak BioSciences, Inc. | Extracellular vesicles with antisense oligonucleotides targeting kras |
| WO2021030773A1 (en) | 2019-08-14 | 2021-02-18 | Codiak Biosciences, Inc. | Extracellular vesicle-nlrp3 antagonist |
| CN114729327A (zh) | 2019-08-14 | 2022-07-08 | 科迪亚克生物科学公司 | 具有stat3反义寡核苷酸的细胞外囊泡 |
| WO2021043221A1 (en) | 2019-09-04 | 2021-03-11 | Biosion Inc. | Antibodies binding tslp and uses thereof |
| EP4026911A4 (en) * | 2019-09-05 | 2023-12-13 | National University Corporation Tokyo University Of Agriculture and Technology | Tryptase activity measurement substrate |
| WO2021055306A1 (en) | 2019-09-16 | 2021-03-25 | Bristol-Myers Squibb Company | Dual capture method for analysis of antibody-drug conjugates |
| US12319711B2 (en) | 2019-09-20 | 2025-06-03 | Northwestern University | Spherical nucleic acids with tailored and active protein coronae |
| US12378560B2 (en) | 2019-10-29 | 2025-08-05 | Northwestern University | Sequence multiplicity within spherical nucleic acids |
| CN114981309B (zh) | 2020-01-03 | 2023-08-25 | 博奥信生物技术（南京）有限公司 | 结合bcma的抗体及其用途 |
| CN114945409A (zh) | 2020-01-13 | 2022-08-26 | 新免疫技术有限公司 | 用il-7蛋白和双特异性抗体的组合治疗肿瘤的方法 |
| JP7726628B2 (ja) * | 2020-01-30 | 2025-08-20 | エイムドバイオ株式会社 | ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体－薬物複合体 |
| KR20220147642A (ko) | 2020-02-27 | 2022-11-03 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | Il4r에 결합하는 항체 및 이의 용도 |
| EP4132971A1 (en) | 2020-04-09 | 2023-02-15 | Merck Sharp & Dohme LLC | Affinity matured anti-lap antibodies and uses thereof |
| US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
| US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
| CN112255908B (zh) * | 2020-11-16 | 2024-12-03 | 西安轻工业钟表研究所有限公司 | 一种指针式卫星光伏时钟 |
| CN112553274B (zh) * | 2020-12-02 | 2023-06-13 | 江南大学 | 大豆提取物Bowman-Birk inhibitor切割DNA的方法 |
| CN114685669A (zh) | 2020-12-30 | 2022-07-01 | 和铂医药(苏州)有限公司 | 结合trop2的抗体及其用途 |
| WO2022178180A1 (en) | 2021-02-17 | 2022-08-25 | Codiak Biosciences, Inc. | Extracellular vesicle linked to a biologically active molecule via an optimized linker and an anchoring moiety |
| AU2022238571A1 (en) | 2021-03-18 | 2023-09-14 | Seagen Inc. | Selective drug release from internalized conjugates of biologically active compounds |
| US20240376224A1 (en) | 2021-04-02 | 2024-11-14 | The Regents Of The University Of California | Antibodies against cleaved cdcp1 and uses thereof |
| US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
| JP2024539749A (ja) | 2021-10-14 | 2024-10-29 | ラッティコン （スージョウ） バイオファーマシューティカルズ カンパニー リミテッド | 新規な抗体－サイトカイン融合タンパク質及びその製造方法と使用 |
| CN114181216A (zh) * | 2021-12-27 | 2022-03-15 | 苏州新药篮生物医药科技有限公司 | 一种3,6-二氢吡咯并[3,2-e]吲哚-2-甲酸甲酯的制备方法 |
| JP2025507144A (ja) | 2022-03-18 | 2025-03-13 | ベイジン マブワークス バイオテック カンパニー リミテッド | 抗体結合ｂ７－ｈ３及びその使用 |
| CN116727114B (zh) * | 2023-07-19 | 2024-07-09 | 昆明理工大学 | 一种短流程浮选回收锂云母的方法 |
| WO2025184208A1 (en) | 2024-02-27 | 2025-09-04 | Bristol-Myers Squibb Company | Anti-ceacam5 antibodies and uses thereof |
| WO2025185559A1 (zh) * | 2024-03-04 | 2025-09-12 | 杭州中美华东制药有限公司 | 抗FGFR2b抗体、其抗体药物偶联物及其用途 |
| WO2025188694A1 (en) | 2024-03-05 | 2025-09-12 | Bristol-Myers Squibb Company | Tricyclic tlr7 agonists and uses thereof |
| WO2025188693A1 (en) | 2024-03-05 | 2025-09-12 | Bristol-Myers Squibb Company | Bicyclic tlr7 agonists and uses thereof |
Family Cites Families (118)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4169888A (en) | 1977-10-17 | 1979-10-02 | The Upjohn Company | Composition of matter and process |
| US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4978757A (en) | 1984-02-21 | 1990-12-18 | The Upjohn Company | 1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds |
| US4912227A (en) | 1984-02-21 | 1990-03-27 | The Upjohn Company | 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| JPH0684377B2 (ja) | 1986-04-17 | 1994-10-26 | 協和醗酵工業株式会社 | 新規化合物ｄｃ―８８ａ及びｄｃ―８９ａ１ |
| US5332837A (en) | 1986-12-19 | 1994-07-26 | The Upjohn Company | CC-1065 analogs |
| US4975278A (en) | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| US5773435A (en) | 1987-08-04 | 1998-06-30 | Bristol-Myers Squibb Company | Prodrugs for β-lactamase and uses thereof |
| US4952394A (en) | 1987-11-23 | 1990-08-28 | Bristol-Myers Company | Drug-monoclonal antibody conjugates |
| US4994578A (en) | 1987-11-27 | 1991-02-19 | Meiji Seika Kaisha, Ltd. | Certain anti-tumor duocarmycin antibiotics from streptomyces |
| US5147786A (en) | 1988-04-22 | 1992-09-15 | Monsanto Company | Immunoassay for the detection of α-haloacetamides |
| JP2642165B2 (ja) | 1988-07-22 | 1997-08-20 | 協和醗酵工業株式会社 | 新規ｄｃ−８９化合物およびその製造法 |
| US5084468A (en) | 1988-08-11 | 1992-01-28 | Kyowa Hakko Kogyo Co., Ltd. | Dc-88a derivatives |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5176996A (en) | 1988-12-20 | 1993-01-05 | Baylor College Of Medicine | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| JP2598116B2 (ja) | 1988-12-28 | 1997-04-09 | 協和醗酵工業株式会社 | 新規物質ｄｃ１１３ |
| US5187186A (en) | 1989-07-03 | 1993-02-16 | Kyowa Hakko Kogyo Co., Ltd. | Pyrroloindole derivatives |
| JP2510335B2 (ja) | 1989-07-03 | 1996-06-26 | 協和醗酵工業株式会社 | Ｄｃ―８８ａ誘導体 |
| WO1991004753A1 (en) | 1989-10-02 | 1991-04-18 | Cetus Corporation | Conjugates of antisense oligonucleotides and therapeutic uses thereof |
| US5495009A (en) | 1989-10-24 | 1996-02-27 | Gilead Sciences, Inc. | Oligonucleotide analogs containing thioformacetal linkages |
| US5334528A (en) | 1989-10-30 | 1994-08-02 | The Regents Of The University Of California | Monoclonal antibodies to cyclodiene insecticides and method for detecting the same |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| ATE139258T1 (de) | 1990-01-12 | 1996-06-15 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| JPH05508394A (ja) | 1990-04-25 | 1993-11-25 | ファルマシア・アンド・アップジョン・カンパニー | 新規なｃｃ―１０６５アナログ |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| US5137877B1 (en) | 1990-05-14 | 1996-01-30 | Bristol Myers Squibb Co | Bifunctional linking compounds conjugates and methods for their production |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| DE69121334T2 (de) | 1990-07-26 | 1997-03-20 | Kyowa Hakko Kogyo Kk | DC-89-Derivate als Antitumor-Wirkstoffe |
| GB9017024D0 (en) | 1990-08-03 | 1990-09-19 | Erba Carlo Spa | New linker for bioactive agents |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| AU8507191A (en) | 1990-08-29 | 1992-03-30 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5789650A (en) | 1990-08-29 | 1998-08-04 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| WO1993011236A1 (en) | 1991-12-02 | 1993-06-10 | Medical Research Council | Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| US5622929A (en) | 1992-01-23 | 1997-04-22 | Bristol-Myers Squibb Company | Thioether conjugates |
| DK0563475T3 (da) | 1992-03-25 | 2000-09-18 | Immunogen Inc | Konjugater af cellebindende midler og derivater af CC-1065 |
| GB9314960D0 (en) | 1992-07-23 | 1993-09-01 | Zeneca Ltd | Chemical compounds |
| JP3514490B2 (ja) | 1992-08-21 | 2004-03-31 | 杏林製薬株式会社 | トリフルオロメチルピロロインドールカルボン酸エステル誘導体及びその製造方法 |
| US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
| US5324483B1 (en) | 1992-10-08 | 1996-09-24 | Warner Lambert Co | Apparatus for multiple simultaneous synthesis |
| DE4314091A1 (de) | 1993-04-29 | 1994-11-03 | Boehringer Mannheim Gmbh | Immunologisches Nachweisverfahren für Triazine |
| US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| US5786377A (en) | 1993-11-19 | 1998-07-28 | Universidad De Santiago De Compostela | Pyrrolo 3,2-E!indol derivatives, process for the preparation thereof and applications |
| PT705833E (pt) | 1994-04-22 | 2004-11-30 | Kyowa Hakko Kogyo Kk | Derivado de dc-89 |
| JPH07309761A (ja) | 1994-05-20 | 1995-11-28 | Kyowa Hakko Kogyo Co Ltd | デュオカルマイシン誘導体の安定化法 |
| US5773001A (en) | 1994-06-03 | 1998-06-30 | American Cyanamid Company | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| ES2297832T3 (es) | 1994-08-19 | 2008-05-01 | La Region Wallonne | Conjugados que comprenden un agente antitumoral y su utilizacion. |
| EP0786252A4 (en) | 1994-09-30 | 1998-01-07 | Kyowa Hakko Kogyo Kk | ANTI-TUMOR AGENT |
| AU693283B2 (en) | 1994-11-29 | 1998-06-25 | Kyorin Pharmaceutical Co. Ltd. | Acrylamide derivatives and process for producing the same |
| WO1996035451A1 (en) | 1995-05-10 | 1996-11-14 | Kyowa Hakko Kogyo Co., Ltd. | Novel toxin complex |
| US5686237A (en) | 1995-06-05 | 1997-11-11 | Al-Bayati; Mohammed A. S. | Use of biomarkers in saliva to evaluate the toxicity of agents and the function of tissues in both biomedical and environmental applications |
| US5714586A (en) | 1995-06-07 | 1998-02-03 | American Cyanamid Company | Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates |
| US5712374A (en) | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| JPH11513391A (ja) | 1995-10-03 | 1999-11-16 | ザ スクリップス リサーチ インスティテュート | Ｃｃ−１０６５ 及びズオカーマイシンのｃｂｉ 類縁体 |
| EP0774464B1 (en) | 1995-10-17 | 2004-07-28 | Combichem, Inc. | A template for solution phase synthesis of combinatorial libraries |
| WO1997023243A1 (en) | 1995-12-22 | 1997-07-03 | Bristol-Myers Squibb Company | Branched hydrazone linkers |
| US6143901A (en) | 1996-07-31 | 2000-11-07 | Genesoft, Inc. | Complex formation between dsDNA and pyrrole imidazole polyamides |
| DE69733942T2 (de) | 1996-03-08 | 2006-06-08 | The Scripps Research Institute, La Jolla | Mcbi analoge von cc-1065 und die duocarmycine |
| AU3217897A (en) | 1996-05-31 | 1998-01-05 | Scripps Research Institute, The | Analogs of cc-1065 and the duocarmycins |
| US6130237A (en) | 1996-09-12 | 2000-10-10 | Cancer Research Campaign Technology Limited | Condensed N-aclyindoles as antitumor agents |
| EP0938474B1 (en) | 1996-09-12 | 2005-11-23 | Auckland Uniservices Limited | Cyclopropylindole compounds and their use as prodrugs |
| JPH1087666A (ja) | 1996-09-18 | 1998-04-07 | Kyorin Pharmaceut Co Ltd | デュオカルマイシンｓａ及びその誘導体の製造中間体と製造方法 |
| US6759509B1 (en) | 1996-11-05 | 2004-07-06 | Bristol-Myers Squibb Company | Branched peptide linkers |
| WO1998025900A1 (en) | 1996-12-13 | 1998-06-18 | Shionogi & Co., Ltd. | Compounds having antitumor activity |
| CA2285259A1 (en) | 1997-03-28 | 1998-10-08 | The Scripps Research Institute | Sandramycin analogs |
| WO1998050432A1 (en) | 1997-05-07 | 1998-11-12 | Bristol-Myers Squibb Company | Recombinant antibody-enzyme fusion proteins |
| EP0983248B1 (en) | 1997-05-22 | 2004-07-14 | The Scripps Research Institute | Analogs of duocarmycin and cc-1065 |
| NZ503966A (en) | 1997-10-14 | 2002-10-25 | Scripps Research Inst | iso -CBI and iso -CI analogs of CC-1065 and the duocarmycins |
| US6310209B1 (en) | 1997-12-08 | 2001-10-30 | The Scripps Research Institute | Synthesis of CC-1065/duocarmycin analogs |
| JP3045706B1 (ja) | 1998-09-14 | 2000-05-29 | 科学技術振興事業団 | Ｄｎａの特定塩基配列をアルキル化する化合物及びその合成法 |
| US7425541B2 (en) | 1998-12-11 | 2008-09-16 | Medarex, Inc. | Enzyme-cleavable prodrug compounds |
| PT1144011E (pt) | 1998-12-11 | 2010-06-16 | Coulter Pharm Inc | Compostos pró-fármacos e processo para a sua preparação |
| US6909006B1 (en) | 1999-08-27 | 2005-06-21 | Spirogen Limited | Cyclopropylindole derivatives |
| NZ518764A (en) | 1999-12-29 | 2004-02-27 | Immunogen Inc | Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| US6555693B2 (en) | 2000-03-16 | 2003-04-29 | Genesoft, Inc. | Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| AU2001262974A1 (en) | 2000-05-03 | 2001-11-12 | The Scripps Research Institute | Dna alkylating agent and activation thereof |
| JP4061819B2 (ja) | 2000-05-12 | 2008-03-19 | 独立行政法人科学技術振興機構 | インターストランドクロスリンク剤の合成方法 |
| AU7552501A (en) | 2000-06-14 | 2002-01-08 | Corixa Corp | Tripeptide prodrug compounds |
| WO2001095943A2 (en) | 2000-06-14 | 2001-12-20 | Medarex, Inc. | Prodrug compounds with an oligopeptide having an isoleucine residue |
| WO2002015700A1 (en) | 2000-08-24 | 2002-02-28 | Coulter Pharmaceutical, Inc. | Prodrugs activated by plasmin and their use in cancer chemotherapy |
| EP1243276A1 (en) | 2001-03-23 | 2002-09-25 | Franciscus Marinus Hendrikus De Groot | Elongated and multiple spacers containing activatible prodrugs |
| JP2002308898A (ja) * | 2001-04-06 | 2002-10-23 | Kyowa Hakko Kogyo Co Ltd | 蛋白質受容体結合性環状ペプチドおよびその製造法 |
| US20030083263A1 (en) | 2001-04-30 | 2003-05-01 | Svetlana Doronina | Pentapeptide compounds and uses related thereto |
| US7256257B2 (en) | 2001-04-30 | 2007-08-14 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| MXPA03010961A (es) | 2001-05-31 | 2004-02-27 | Vertex Pharma | Compuestos de tiazol utiles como inhibidores de proteinas cinasas. |
| MXPA03011094A (es) | 2001-05-31 | 2004-12-06 | Medarex Inc | Citotoxinas, profarmacos, ligadores, y estabilizadores utiles para ello. |
| DE60239679D1 (de) | 2001-06-11 | 2011-05-19 | Medarex Inc | Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen |
| CA2459308A1 (en) | 2001-09-07 | 2003-03-20 | Dale L. Boger | Cbi analogues of cc-1065 and the duocarmycins |
| US7091186B2 (en) | 2001-09-24 | 2006-08-15 | Seattle Genetics, Inc. | p-Amidobenzylethers in drug delivery agents |
| US6756397B2 (en) | 2002-04-05 | 2004-06-29 | Immunogen, Inc. | Prodrugs of CC-1065 analogs |
| US6534660B1 (en) | 2002-04-05 | 2003-03-18 | Immunogen, Inc. | CC-1065 analog synthesis |
| DK1523493T3 (da) | 2002-07-09 | 2013-12-02 | Alexander Doemling | Nye tubulysinanaloge |
| US7776814B2 (en) | 2002-07-09 | 2010-08-17 | R&D-Biopharmaceuticals Gmbh | Tubulysin conjugates |
| US20050180972A1 (en) | 2002-07-31 | 2005-08-18 | Wahl Alan F. | Anti-CD20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| EP2517729A3 (en) * | 2003-01-27 | 2013-01-02 | Endocyte, Inc. | Vitamin receptor binding drug delivery conjugates |
| WO2004101767A2 (en) | 2003-05-13 | 2004-11-25 | The Scripps Research Institute | Cbi analogues of the duocarmycins and cc-1065 |
| CA2564076C (en) * | 2004-05-19 | 2014-02-18 | Medarex, Inc. | Chemical linkers and conjugates thereof |
| EP1789391B1 (en) * | 2004-07-23 | 2017-06-28 | Endocyte, Inc. | Bivalent linkers and conjugates thereof |
| US7714016B2 (en) * | 2005-04-08 | 2010-05-11 | Medarex, Inc. | Cytotoxic compounds and conjugates with cleavable substrates |
| CN101312748A (zh) | 2005-09-26 | 2008-11-26 | 梅达莱克斯公司 | 抗体-药物轭合物和使用方法 |
| CA2627190A1 (en) | 2005-11-10 | 2007-05-24 | Medarex, Inc. | Duocarmycin derivatives as novel cytotoxic compounds and conjugates |
| RU2489423C2 (ru) | 2006-02-02 | 2013-08-10 | Синтарга Б.В. | Водорастворимые аналоги сс-1065 и их конъюгаты |
| WO2008074004A2 (en) | 2006-12-14 | 2008-06-19 | Medarex, Inc. | Human antibodies that bind cd70 and uses thereof |
| CA2678514A1 (en) * | 2007-02-21 | 2008-08-28 | Medarex, Inc. | Chemical linkers with single amino acids and conjugates thereof |
-
2007
- 2007-12-27 TW TW096150517A patent/TWI412367B/zh not_active IP Right Cessation
- 2007-12-28 MX MX2009007147A patent/MX2009007147A/es active IP Right Grant
- 2007-12-28 EP EP07870071A patent/EP2114454A2/en not_active Withdrawn
- 2007-12-28 US US12/521,391 patent/US8461117B2/en active Active
- 2007-12-28 BR BRPI0719626-1A2A patent/BRPI0719626A2/pt not_active IP Right Cessation
- 2007-12-28 EA EA200970648A patent/EA019962B1/ru not_active IP Right Cessation
- 2007-12-28 CN CN200780051809A patent/CN101795711A/zh active Pending
- 2007-12-28 KR KR1020097015600A patent/KR20090098901A/ko not_active Ceased
- 2007-12-28 CA CA2674055A patent/CA2674055C/en not_active Expired - Fee Related
- 2007-12-28 NZ NZ578324A patent/NZ578324A/en not_active IP Right Cessation
- 2007-12-28 JP JP2009544303A patent/JP2010522693A/ja active Pending
- 2007-12-28 CL CL200703849A patent/CL2007003849A1/es unknown
- 2007-12-28 WO PCT/US2007/089100 patent/WO2008083312A2/en not_active Ceased
- 2007-12-28 SG SG201101561-7A patent/SG170070A1/en unknown
- 2007-12-28 AR ARP070105968A patent/AR067837A1/es unknown
- 2007-12-28 AU AU2007342052A patent/AU2007342052A1/en not_active Abandoned
-
2009
- 2009-06-17 IL IL199416A patent/IL199416A0/en unknown
- 2009-07-20 NO NO20092733A patent/NO20092733L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010522693A5 (cg-RX-API-DMAC7.html) | ||
| CN102351931B (zh) | 嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用 | |
| ES2566797T3 (es) | Compuestos de polímero de polialquileno y usos de éstos | |
| ES2739613T3 (es) | Péptidos que penetran en las células y sus métodos de preparación y su uso | |
| RU2006144958A (ru) | Химические линкеры и их конъюгаты | |
| JP6539729B2 (ja) | ペプチド−薬物複合体 | |
| ES2375843T3 (es) | Procedimientos y compuestos para la preparación de an�?logos de cc-1065. | |
| ES2347546T3 (es) | Profarmacos conjugados de analogos de cc-1065. | |
| CN105849086B (zh) | 亲水性链接体及其在药物分子和细胞结合分子共轭反应上的应用 | |
| ES2371411T3 (es) | Nanopartículas de derivados de la gemcitabina. | |
| JP2020122023A5 (cg-RX-API-DMAC7.html) | ||
| JP2005532287A5 (cg-RX-API-DMAC7.html) | ||
| JP2010521485A5 (cg-RX-API-DMAC7.html) | ||
| Baraldi et al. | Hybrid molecules between distamycin A and active moieties of antitumor agents | |
| TW200900059A (en) | Chemical linkers with single amino acids and conjugates thereof | |
| ES2909486T3 (es) | Sistemas de administración para liberación controlada de fármaco | |
| JP2009504784A5 (cg-RX-API-DMAC7.html) | ||
| CY1112086T1 (el) | Συνδυασμος γλυκοπυρρολικου αλατος και ενος αγωνιστη βητα2 αδρενεργικων υποδοχεων | |
| JP2014506892A5 (cg-RX-API-DMAC7.html) | ||
| JP2019512492A (ja) | Ｐｅｇ化薬物リンカー及びその中間体を調製するためのプロセス | |
| AU2014333954B2 (en) | Protecting group comprising a purification tag | |
| PT1268418E (pt) | Derivados da pirrolidina farmacologicamente activos com inibidores bax | |
| CN108601952B (zh) | 雷公藤内酯的葡萄糖缀合物、类似物及其用途 | |
| JP2020519610A5 (cg-RX-API-DMAC7.html) | ||
| CN105431546A (zh) | 基于活性的探针化合物、组合物及其使用方法 |